Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Journal
Age
Showing 1 to 12 of 51874 entries
Sorted by: Best Match Show Resources per page
[Use of plasmapheresis in the treatment of hemolytic-uremic syndrome in children].

La Pediatria medica e chirurgica : Medical and surgical pediatrics

Salvatori G, Rinaldi S, Landolfo A, Totino T, Salvatori A, Signoretti A.
PMID: 3786202
Pediatr Med Chir. 1986 May-Jun;8(3):383-7.

The plasma-exchange has been recently adopted in the therapy of the hemolytic-uremic syndrome. We experimented this therapy, without any complication with traditional treatment (anti platelet-aggregation, frozen fresh plasma), on a child of 6 years and 8 months old. A...

Cite
Salvatori G, Rinaldi S, Landolfo A, et al. Sull'impiego della plasmaferesi nel trattamento della sindrome uremico-emolitica nel bambino. [Use of plasmapheresis in the treatment of hemolytic-uremic syndrome in children]. Pediatr Med Chir. 1986;8(3):383-7
Salvatori, G., Rinaldi, S., Landolfo, A., Totino, T., Salvatori, A., & Signoretti, A. (1986). Sull'impiego della plasmaferesi nel trattamento della sindrome uremico-emolitica nel bambino. [Use of plasmapheresis in the treatment of hemolytic-uremic syndrome in children]. La Pediatria medica e chirurgica : Medical and surgical pediatrics, 8(3), 383-7.
Salvatori, G, et al. "Sull'impiego della plasmaferesi nel trattamento della sindrome uremico-emolitica nel bambino." [Use of plasmapheresis in the treatment of hemolytic-uremic syndrome in children]. La Pediatria medica e chirurgica : Medical and surgical pediatrics vol. 8,3 (1986): 383-7.
Salvatori G, Rinaldi S, Landolfo A, Totino T, Salvatori A, Signoretti A. Sull'impiego della plasmaferesi nel trattamento della sindrome uremico-emolitica nel bambino. [Use of plasmapheresis in the treatment of hemolytic-uremic syndrome in children]. Pediatr Med Chir. 1986 May-Jun;8(3):383-7. Italian. PMID: 3786202.
Copy Download .nbib Format: NLM
Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response.

Transplantation

Burlingham WJ, Sparks EM, Sondel PM, Glass NR, Belzer FO, Sollinger HW.
PMID: 3155578
Transplantation. 1985 Jan;39(1):12-7.

Our purpose was to identify humoral factors induced by donor-specific transfusion (DST) plus azathioprine (AZA) that correlate with improved renal allograft survival (92% at 3-34 months posttransplantation) in a group of 24 DST patients. Plasma was obtained from patients...

Cite
Burlingham WJ, Sparks EM, Sondel PM, et al. Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response. Transplantation. 1985;39(1):12-7
Burlingham, W. J., Sparks, E. M., Sondel, P. M., Glass, N. R., Belzer, F. O., & Sollinger, H. W. (1985). Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response. Transplantation, 39(1), 12-7.
Burlingham, W J, et al. "Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response." Transplantation vol. 39,1 (1985): 12-7.
Burlingham WJ, Sparks EM, Sondel PM, Glass NR, Belzer FO, Sollinger HW. Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response. Transplantation. 1985 Jan;39(1):12-7. PMID: 3155578.
Copy Download .nbib Format: NLM
High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery.

Acta anaesthesiologica Belgica

Biagini A, Comite C, Russo V, Salerno ML, Gemignani R, Pardelli S, Baccellini M, Baroni M, Pugliese S, Maffei S.
PMID: 1280394
Acta Anaesthesiol Belg. 1992;43(3):181-6.

Recently, aprotinin has been demonstrated to be effective in reducing post-operative bleeding after open heart surgery. The aim of this study was to evaluate the effectiveness of high dose aprotinin in patients undergoing redo open heart surgery in whom...

Cite
Biagini A, Comite C, Russo V, et al. High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery. Acta Anaesthesiol Belg. 1992;43(3):181-6
Biagini, A., Comite, C., Russo, V., Salerno, M. L., Gemignani, R., Pardelli, S., Baccellini, M., Baroni, M., Pugliese, S., & Maffei, S. (1992). High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery. Acta anaesthesiologica Belgica, 43(3), 181-6.
Biagini, A, et al. "High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery." Acta anaesthesiologica Belgica vol. 43,3 (1992): 181-6.
Biagini A, Comite C, Russo V, Salerno ML, Gemignani R, Pardelli S, Baccellini M, Baroni M, Pugliese S, Maffei S. High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery. Acta Anaesthesiol Belg. 1992;43(3):181-6. PMID: 1280394.
Copy Download .nbib Format: NLM
[Transfusion strategy in substitution with thrombocytes and granulocytes].

Beitrage zu Infusionstherapie und klinische Ernahrung

Wiesneth M.
PMID: 2830874
Beitr Infusionther Klin Ernahr. 1987;18:108-14.

No abstract available.

Cite
Wiesneth M. Transfusionsstrategie bei der Substitution mit Thrombozyten und Granulozyten. [Transfusion strategy in substitution with thrombocytes and granulocytes]. Beitr Infusionther Klin Ernahr. 1987;18:108-14
Wiesneth, M. (1987). Transfusionsstrategie bei der Substitution mit Thrombozyten und Granulozyten. [Transfusion strategy in substitution with thrombocytes and granulocytes]. Beitrage zu Infusionstherapie und klinische Ernahrung, 18108-14.
Wiesneth, M. "Transfusionsstrategie bei der Substitution mit Thrombozyten und Granulozyten." [Transfusion strategy in substitution with thrombocytes and granulocytes]. Beitrage zu Infusionstherapie und klinische Ernahrung vol. 18 (1987): 108-14.
Wiesneth M. Transfusionsstrategie bei der Substitution mit Thrombozyten und Granulozyten. [Transfusion strategy in substitution with thrombocytes and granulocytes]. Beitr Infusionther Klin Ernahr. 1987;18:108-14. German. PMID: 2830874.
Copy Download .nbib Format: NLM
[GEK-NEU: triply washed erythrocytes from O Rh-negative and CMV-seronegative donors withdrawn less than 4 days before transfusion into newborn infants at risk].

Beitrage zu Infusionstherapie und klinische Ernahrung

Diekamp U, Miceli C, Gylys L, Caccese M.
PMID: 2830875
Beitr Infusionther Klin Ernahr. 1987;18:133-9.

No abstract available.

Cite
Diekamp U, Miceli C, Gylys L, et al. GEK-NEU: dreimal gewaschene Erythrozyten von 0 Rh negativen und CMV-seronegativen Spendern, vor weniger als vier Tagen entnommen, zur Transfusion an Risikoneugeborenen. [GEK-NEU: triply washed erythrocytes from O Rh-negative and CMV-seronegative donors withdrawn less than 4 days before transfusion into newborn infants at risk]. Beitr Infusionther Klin Ernahr. 1987;18:133-9
Diekamp, U., Miceli, C., Gylys, L., & Caccese, M. (1987). GEK-NEU: dreimal gewaschene Erythrozyten von 0 Rh negativen und CMV-seronegativen Spendern, vor weniger als vier Tagen entnommen, zur Transfusion an Risikoneugeborenen. [GEK-NEU: triply washed erythrocytes from O Rh-negative and CMV-seronegative donors withdrawn less than 4 days before transfusion into newborn infants at risk]. Beitrage zu Infusionstherapie und klinische Ernahrung, 18133-9.
Diekamp, U, et al. "GEK-NEU: dreimal gewaschene Erythrozyten von 0 Rh negativen und CMV-seronegativen Spendern, vor weniger als vier Tagen entnommen, zur Transfusion an Risikoneugeborenen." [GEK-NEU: triply washed erythrocytes from O Rh-negative and CMV-seronegative donors withdrawn less than 4 days before transfusion into newborn infants at risk]. Beitrage zu Infusionstherapie und klinische Ernahrung vol. 18 (1987): 133-9.
Diekamp U, Miceli C, Gylys L, Caccese M. GEK-NEU: dreimal gewaschene Erythrozyten von 0 Rh negativen und CMV-seronegativen Spendern, vor weniger als vier Tagen entnommen, zur Transfusion an Risikoneugeborenen. [GEK-NEU: triply washed erythrocytes from O Rh-negative and CMV-seronegative donors withdrawn less than 4 days before transfusion into newborn infants at risk]. Beitr Infusionther Klin Ernahr. 1987;18:133-9. German. PMID: 2830875.
Copy Download .nbib Format: NLM
Kasabach-Merritt syndrome: therapeutic considerations.

Pediatrics

Larsen EC, Zinkham WH, Eggleston JC, Zitelli BJ.
PMID: 3108848
Pediatrics. 1987 Jun;79(6):971-80.

During the past 15 years we have managed six children with capillary hemangiomas in association with consumptive coagulopathy--the Kasabach-Merritt syndrome. Their ages when first seen ranged from 2 weeks to 4 years with a mean of 19 months. In...

Cite
Larsen EC, Zinkham WH, Eggleston JC, et al. Kasabach-Merritt syndrome: therapeutic considerations. Pediatrics. 1987;79(6):971-80
Larsen, E. C., Zinkham, W. H., Eggleston, J. C., & Zitelli, B. J. (1987). Kasabach-Merritt syndrome: therapeutic considerations. Pediatrics, 79(6), 971-80.
Larsen, E C, et al. "Kasabach-Merritt syndrome: therapeutic considerations." Pediatrics vol. 79,6 (1987): 971-80.
Larsen EC, Zinkham WH, Eggleston JC, Zitelli BJ. Kasabach-Merritt syndrome: therapeutic considerations. Pediatrics. 1987 Jun;79(6):971-80. PMID: 3108848.
Copy Download .nbib Format: NLM
Regrafts.

Clinical transplants

Cabacungan C.
PMID: 1306711
Clin Transpl. 1992;347-56.

1. Retransplant survival rates have been increasing at a much faster rate than those of first transplants. The difference between first and second transplant 1-year survival rates has decreased from 8% in 1988 to 2% in 1991. 2. Second...

Cite
Cabacungan C. Regrafts. Clin Transpl. 1992;347-56
Cabacungan, C. (1992). Regrafts. Clinical transplants, 347-56.
Cabacungan, C. "Regrafts." Clinical transplants vol. (1992): 347-56.
Cabacungan C. Regrafts. Clin Transpl. 1992;347-56. PMID: 1306711.
Copy Download .nbib Format: NLM
[Repercussions of blood transmission in the epidemiology of AIDS-HIV infection in Mexican children].

Boletin medico del Hospital Infantil de Mexico

Volkow-Fernández P.
PMID: 1388790
Bol Med Hosp Infant Mex. 1992 Sep;49(9):628-30.

The first case of AIDS associated with contaminated blood products occurred in a child; with this 2 very important situations were recognized, firstly, the possibility of transmitting the disease through blood products, and secondly, that children are not exempt...

Cite
Volkow-Fernández P. Repercusión de la transmisión sanguínea en la epidemiología de la infección por HIV-SIDA en niños mexicanos. [Repercussions of blood transmission in the epidemiology of AIDS-HIV infection in Mexican children]. Bol Med Hosp Infant Mex. 1992;49(9):628-30
Volkow-Fernández, P. (1992). Repercusión de la transmisión sanguínea en la epidemiología de la infección por HIV-SIDA en niños mexicanos. [Repercussions of blood transmission in the epidemiology of AIDS-HIV infection in Mexican children]. Boletin medico del Hospital Infantil de Mexico, 49(9), 628-30.
Volkow-Fernández, P. "Repercusión de la transmisión sanguínea en la epidemiología de la infección por HIV-SIDA en niños mexicanos." [Repercussions of blood transmission in the epidemiology of AIDS-HIV infection in Mexican children]. Boletin medico del Hospital Infantil de Mexico vol. 49,9 (1992): 628-30.
Volkow-Fernández P. Repercusión de la transmisión sanguínea en la epidemiología de la infección por HIV-SIDA en niños mexicanos. [Repercussions of blood transmission in the epidemiology of AIDS-HIV infection in Mexican children]. Bol Med Hosp Infant Mex. 1992 Sep;49(9):628-30. Spanish. PMID: 1388790.
Copy Download .nbib Format: NLM
The effect of donor-specific blood transfusion on in vitro alloreactive precursor cell frequencies.

Transplantation proceedings

Duffy B, Tyler J, Anderson C, Hanto D, Flye W, Rodey G.
PMID: 2978930
Transplant Proc. 1987 Feb;19(1):753-4.

No abstract available.

Cite
Duffy B, Tyler J, Anderson C, et al. The effect of donor-specific blood transfusion on in vitro alloreactive precursor cell frequencies. Transplant Proc. 1987;19(1):753-4
Duffy, B., Tyler, J., Anderson, C., Hanto, D., Flye, W., & Rodey, G. (1987). The effect of donor-specific blood transfusion on in vitro alloreactive precursor cell frequencies. Transplantation proceedings, 19(1), 753-4.
Duffy, B, et al. "The effect of donor-specific blood transfusion on in vitro alloreactive precursor cell frequencies." Transplantation proceedings vol. 19,1 (1987): 753-4.
Duffy B, Tyler J, Anderson C, Hanto D, Flye W, Rodey G. The effect of donor-specific blood transfusion on in vitro alloreactive precursor cell frequencies. Transplant Proc. 1987 Feb;19(1):753-4. PMID: 2978930.
Copy Download .nbib Format: NLM
Host defenses in the neonate: prospects for enhancement.

Seminars in perinatology

Hill HR.
PMID: 3881826
Semin Perinatol. 1985 Jan;9(1):2-11.

No abstract available.

Cite
Hill HR. Host defenses in the neonate: prospects for enhancement. Semin Perinatol. 1985;9(1):2-11
Hill, H. R. (1985). Host defenses in the neonate: prospects for enhancement. Seminars in perinatology, 9(1), 2-11.
Hill, H R. "Host defenses in the neonate: prospects for enhancement." Seminars in perinatology vol. 9,1 (1985): 2-11.
Hill HR. Host defenses in the neonate: prospects for enhancement. Semin Perinatol. 1985 Jan;9(1):2-11. PMID: 3881826.
Copy Download .nbib Format: NLM
The effect of leukocyte transfusions on experimental bacteremia in the dog.

Blood

Epstein RB, Clift RA, Thomas ED.
PMID: 4904046
Blood. 1969 Dec;34(6):782-90.

No abstract available.

Cite
Epstein RB, Clift RA, Thomas ED. The effect of leukocyte transfusions on experimental bacteremia in the dog. Blood. 1969;34(6):782-90
Epstein, R. B., Clift, R. A., & Thomas, E. D. (1969). The effect of leukocyte transfusions on experimental bacteremia in the dog. Blood, 34(6), 782-90.
Epstein, R B, et al. "The effect of leukocyte transfusions on experimental bacteremia in the dog." Blood vol. 34,6 (1969): 782-90.
Epstein RB, Clift RA, Thomas ED. The effect of leukocyte transfusions on experimental bacteremia in the dog. Blood. 1969 Dec;34(6):782-90. PMID: 4904046.
Copy Download .nbib Format: NLM
Donor-specific transfusion: a report of the Japanese Renal Transplant Registry.

Clinical transplants

Sonoda T, Ishibashi M.
PMID: 2978999
Clin Transpl. 1987;257-60.

1. The effect of donor-specific blood transfusions (DST) on renal graft survival of HLA one haplotype-mismatched living-related transplant patients was studied, and 1,292 transplant patients reported in the Japanese Renal Transplant Registry were analyzed. In the CsA groups, the...

Cite
Sonoda T, Ishibashi M. Donor-specific transfusion: a report of the Japanese Renal Transplant Registry. Clin Transpl. 1987;257-60
Sonoda, T., & Ishibashi, M. (1987). Donor-specific transfusion: a report of the Japanese Renal Transplant Registry. Clinical transplants, 257-60.
Sonoda, T, and Ishibashi, M. "Donor-specific transfusion: a report of the Japanese Renal Transplant Registry." Clinical transplants vol. (1987): 257-60.
Sonoda T, Ishibashi M. Donor-specific transfusion: a report of the Japanese Renal Transplant Registry. Clin Transpl. 1987;257-60. PMID: 2978999.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 51874 entries